URAMAXIN GT- urea gel 
URAMAXIN GT- uramaxin gt and keradan 
Medimetriks Pharmaceuticals, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Uramaxin(45% Urea)GT PRE-FILLED APPLICATOR

PATIENT INSTRUCTIONS

1. Apply Uramaxin GT to affected nails or skin twice per day, or as directed by a physician.
2. After application, wipe the tip of the tube to remove excess product. Securely place cap back on the tube.

DESCRIPTION:Uramaxin (45% Urea) GT is a keratolytic emollient, which is a gentle, yet potent, tissue softener for nails and/or skin. Each gram of Uramaxin (45% Urea) GT contains 45% Urea, camphor, edetate disodium, eucalyptus oil, hydroxyethyl cellulose, menthol, propylene glycol and purified water.

Urea is a diamide of carbonic acid with the following
chemical structure:

structure

CLINICAL PHARMACOLOGY: Urea gently dissolves the intercellular matrix, which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas. Urea also hydrates and gently dissolves the intercellular matrix of the nail plate, which can result in the softening and eventual debridement of the nail plate.

PHARMACOKINETICS: The mechanism of action of topically applied Urea is not yet known.

INDICATIONS AND USES: For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, devitalized and ingrown nails.

CONTRAINDICATIONS: Known hypersensitivity to any of the listed ingredients.

WARNINGS: For external use only. Avoid contact with eyes, lips or mucous membranes.

PRECAUTIONS: This medication is to be used as directed by a physician and should not be used to treat any condition other than that for which it was prescribed. If redness or irritation occurs, discontinue use.

PREGNANCY: Pregnancy Category B. Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproductive studies are not always predictive of human response, Uramaxin (45% Urea) GT should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS: It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when Uramaxin (45% Urea) GT is administered to a nursing woman.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

ADVERSE REACTIONS: Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.

DOSAGE AND ADMINISTRATION: DIRECTIONS FOR NAILS: Apply Uramaxin (45% Urea) GT to diseased or damaged nail tissue twice per day, or as directed by a physician.

DIRECTIONS FOR SKIN: Apply Uramaxin (45% Urea) GT to affected area(s) twice per day, or as directed by a physician.

HOW SUPPLIED:
Uramaxin (45% Urea) GT 20 mL tube, NDC 43538-250-20

Store at controlled room temperature 15°-30°C (59°-86°F).

Protect from freezing.

Manufactured for:

MEDIMETRIKS
PHARMACEUTICALS, INC.
363 Route 46 West
Fairfield, NJ 07004-2402 USA
www.medimetriks.com

PRINCIPAL DISPLAY PANEL - 20 mL Tube Label

NDC 43538-250-20

Rx Only
Uramaxin®GT
(45% UREA)
PRE-FILLED APPLICATOR

In a vehicle containing Menthol, Camphor and Eucalyptus Oil

0.68 FL OZ (20 mL)
FOR TOPICAL USE ONLY

MEDIMETRIKS
PHARMACEUTICALS, INC.

PRINCIPAL DISPLAY PANEL - 20 mL Tube Label

PRINCIPAL DISPLAY PANEL - 20 mL Tube Carton

NDC 43538-250-20

FOR TOPICAL USE ONLY

Rx Only
Uramaxin®GT
(45% UREA)
PRE-FILLED APPLICATOR

MEDIMETRIKS
PHARMACEUTICALS, INC.

In a vehicle containing Menthol, Camphor and Eucalyptus Oil

0.68 FL OZ (20 mL)

PRINCIPAL DISPLAY PANEL - 20 mL Tube Carton

PRINCIPAL DISPLAY PANEL - 20 mL Tube/255 g Tube Kit Carton

NDC 43538-251-20

Rx Only
Uramaxin®GT KIT
(45% UREA)

KIT CONTENTS:
1 - 0.68 fl. oz. Uramaxin® (45% Urea) GT Pre-filled Applicator Tube
1 - 9 oz. (255 g) Tube Keradan™ Cream

MEDIMETRIKS
PHARMACEUTICALS, INC.

PRINCIPAL DISPLAY PANEL - 20 mL Tube/255 g Tube Kit Carton
URAMAXIN  GT
urea gel
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:43538-250
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
UREA (UNII: 8W8T17847W) (UREA - UNII:8W8T17847W) UREA450 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
EUCALYPTUS OIL (UNII: 2R04ONI662)  
HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) (UNII: ZYD53NBL45)  
LEVOMENTHOL (UNII: BZ1R15MTK7)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:43538-250-201 in 1 CARTON07/08/201001/07/2015
120 mL in 1 TUBE, WITH APPLICATOR; Type 0: Not a Combination Product
2NDC:43538-250-995 mL in 1 TUBE, WITH APPLICATOR; Type 0: Not a Combination Product07/08/201001/07/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/08/201001/07/2015
URAMAXIN GT 
uramaxin gt and keradan kit
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:43538-251
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:43538-251-201 in 1 CARTON04/15/201201/07/2015
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 11 TUBE, WITH APPLICATOR 20 mL
Part 21 TUBE 255 g
Part 1 of 2
URAMAXIN GT 
urea gel
Product Information
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
urea (UNII: 8W8T17847W) (urea - UNII:8W8T17847W) urea450 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
CAMPHOR (SYNTHETIC) (UNII: 5TJD82A1ET)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
EUCALYPTUS OIL (UNII: 2R04ONI662)  
HYDROXYETHYL CELLULOSE (4000 MPA.S AT 1%) (UNII: ZYD53NBL45)  
LEVOMENTHOL (UNII: BZ1R15MTK7)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
120 mL in 1 TUBE, WITH APPLICATOR; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other07/30/201001/07/2015
Part 2 of 2
KERADAN 
moisturizing cream
Product Information
Route of AdministrationTOPICAL
Other Ingredients
Ingredient KindIngredient NameQuantity
INGRwater (UNII: 059QF0KO0R)  
INGRcetostearyl alcohol (UNII: 2DMT128M1S)  
INGRmedium-chain triglycerides (UNII: C9H2L21V7U)  
INGRglycerin (UNII: PDC6A3C0OX)  
INGRcetyl alcohol (UNII: 936JST6JCN)  
INGRpetrolatum (UNII: 4T6H12BN9U)  
INGRpolyoxyl 20 cetostearyl ether (UNII: YRC528SWUY)  
INGRmyristyl trisiloxane (UNII: J7960S4R1T)  
INGRcyclomethicone 5 (UNII: 0THT5PCI0R)  
INGRcyclomethicone 4 (UNII: CZ227117JE)  
INGRstearic acid (UNII: 4ELV7Z65AP)  
INGRparaffin (UNII: I9O0E3H2ZE)  
INGRpolysorbate 20 (UNII: 7T1F30V5YH)  
INGRphenoxyethanol (UNII: HIE492ZZ3T)  
INGRsilicon dioxide (UNII: ETJ7Z6XBU4)  
INGRxanthan gum (UNII: TTV12P4NEE)  
INGRcholesterol (UNII: 97C5T2UQ7J)  
INGRallantoin (UNII: 344S277G0Z)  
INGRyellow wax (UNII: 2ZA36H0S2V)  
INGRmethylparaben (UNII: A2I8C7HI9T)  
INGRlinoleic acid (UNII: 9KJL21T0QJ)  
INGRtrolamine (UNII: 9O3K93S3TK)  
INGRedetate disodium (UNII: 7FLD91C86K)  
INGRsqualane (UNII: GW89575KF9)  
INGR.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
INGRmicrocrystalline wax (UNII: XOF597Q3KY)  
INGRolive oil (UNII: 6UYK2W1W1E)  
INGRaluminum acetate (UNII: 80EHD8I43D)  
INGRaluminum sulfate (UNII: 34S289N54E)  
INGRcalcium acetate (UNII: Y882YXF34X)  
INGRsodium lauroyl lactylate (UNII: 7243K85WFO)  
INGRlinolenic acid (UNII: 0RBV727H71)  
INGRhyaluronate sodium (UNII: YSE9PPT4TH)  
INGRceramide NP (UNII: 4370DF050B)  
INGRceramide AP (UNII: F1X8L2B00J)  
INGRtocopherol (UNII: R0ZB2556P8)  
INGRceramide 1 (UNII: 5THT33P7X7)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1255 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Cosmetic08/01/201101/07/2015
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other04/15/201201/07/2015
Labeler - Medimetriks Pharmaceuticals, Inc. (019903816)

Revised: 11/2017
 
Medimetriks Pharmaceuticals, Inc.